SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-17-067354
Filing Date
2017-11-09
Accepted
2017-11-09 16:02:32
Documents
59
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q a17-20619_110q.htm 10-Q 977964
2 EX-31.1 a17-20619_1ex31d1.htm EX-31.1 12206
3 EX-31.2 a17-20619_1ex31d2.htm EX-31.2 12211
4 EX-32.1 a17-20619_1ex32d1.htm EX-32.1 6809
  Complete submission text file 0001104659-17-067354.txt   4184861

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT catb-20170930.xml EX-101.INS 778877
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT catb-20170930.xsd EX-101.SCH 35736
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT catb-20170930_cal.xml EX-101.CAL 42151
8 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT catb-20170930_lab.xml EX-101.LAB 356633
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT catb-20170930_pre.xml EX-101.PRE 259689
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT catb-20170930_def.xml EX-101.DEF 132584
Mailing Address ONE KENDALL SQUARE BLDG. 1400E, SUITE B14202 CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BLDG. 1400E, SUITE B14202 CAMBRIDGE MA 02139 617-349-1971
CATABASIS PHARMACEUTICALS INC (Filer) CIK: 0001454789 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37467 | Film No.: 171190681
SIC: 2834 Pharmaceutical Preparations